PSP
ALXN

Principal Street Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Principal Street Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,804
Closed -$1.43M – 204
2021
Q2 		$1.43M Sell
7,804
-10,117
-56% -$1.74M 0.38% 59
2021
Q1 		$2.74M Buy
17,921
+6,678
+59% +$1.03M 0.35% 55
2020
Q4 		$1.76M Buy
11,243
+475
+4% +$61K 0.54% 54
2020
Q3 		$1.23M Hold
10,768
– – 0.43% 63
2020
Q2 		$1.21M Sell
10,768
-185
-2% -$19.6K 0.45% 60
2020
Q1 		$984K Buy
10,953
+1,131
+12% +$111K 0.41% 51
2019
Q4 		$1.06M Buy
9,822
+660
+7% +$70.6K 0.24% 75
2019
Q3 		$897K Sell
9,162
-708
-7% -$79.8K 0.22% 79
2019
Q2 		$1.29M Buy
9,870
+4,704
+91% +$606K 0.71% 54
2019
Q1 		$698K Buy
+5,166
New +$642K 0.3% 44

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return